Open Government Portal

Found 10 records similar to Post COVID-19 condition

Federal

The purpose of this document is to assist in planning immunization clinics for COVID-19 vaccines during the COVID-19 pandemic.

Last Updated: Jan. 25, 2021
Date Published: Dec. 12, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, Coronavirus, clinic planning, leadership, coordination, immunization, clinic, human resources, communications
Federal

The World Health Organization (WHO) refers to symptoms lasting for weeks or months after a COVID-19 infection as post COVID-19 condition. Some studies have reported later symptoms in patients with a severe COVID-19 infection. For example, those who were hospitalized or needed intensive care during recovery. However, post COVID-19 condition may also occur for people with mild or asymptomatic infection who were asked to isolate at home during the infectious phase.

Last Updated: Nov. 5, 2021
Date Published: Aug. 20, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, health, professionals, COVID, condition, WHO, symptoms, recovery, vaccination
Federal

COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications.

Last Updated: Apr. 7, 2020
Date Published: Apr. 3, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19 outbreak, pandemic, vaccine for COVID-19, health product submissions and applications
Provincial

As of June 16, all COVID-19 datasets will be updated weekly on Thursdays by 2pm. This dataset details the percentage of COVID-19 positive patients in hospitals and ICUs for COVID-19 related reasons, and for reasons other than COVID-19. Data includes: * reporting date * percentage of COVID-19 positive patients in hospital admitted for COVID-19 * percentage of COVID-19 positive patients in hospital admitted for other reasons * percentage of COVID-19 positive patients in ICU admitted for COVID-19 * percentage of COVID-19 positive patients in ICU admitted for other reasons Due to incomplete weekend and holiday reporting, data for hospital and ICU admissions are not updated on Sundays, Mondays and the day after holidays. This dataset is subject to change.

Last Updated: Aug. 3, 2022
Date Published: Jan. 11, 2022
Organization: Government of Ontario
Formats: CSV HTML
Keywords:  COVID-19, Health, Health and wellness
Federal

Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.

Last Updated: Jul. 27, 2021
Date Published: Mar. 26, 2021
Organization: Health Canada
Formats: HTML
Keywords:  coronavirus, COVID-19, pandemic, drugs, medications, vaccines, market authorization, licensing, importing or selling
Federal

This dataset provides the cumulative number of COVID-19 vaccine doses administered in Canada by jurisdiction, vaccine product, and report date. Variables include:

  • Jurisdiction ID number

  • Jurisdiction

  • Report date

  • Cumulative number of COVID-19 vaccine doses administered

  • Cumulative number of Pfizer-BioNTech COVID-19 vaccine doses administered

  • Cumulative number of Moderna COVID-19 vaccine doses administered

  • Cumulative number of COVID-19 vaccine (unknown product) doses administered

  • As of date

  • Update status

For variable definitions, see the data dictionary. For details regarding data sources and limitations, see the technical notes section of the Canadian COVID-19 vaccination coverage report (https://health-infobase.canada.ca/covid-19/vaccination-coverage/technical-notes.html).

Last Updated: Feb. 5, 2021
Date Published: Feb. 5, 2021
Organization: Public Health Agency of Canada
Formats: CSV
Keywords:  COVID-19, vaccine, vaccination, doses, Pfizer-BioNTech, Moderna
Federal

Pregnancy increases the risk of severe illness from COVID-19. The National Advisory Committee on Immunization (NACI) recommends you get a complete series with an mRNA COVID-19 vaccine if you're pregnant or breastfeeding. Getting the COVID-19 vaccine can prevent serious illness, hospitalization and complications.

Last Updated: Nov. 8, 2021
Date Published: Sep. 24, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Vaccines, NACI, mRNA vaccine, hospitalization, pregnancy, vaccination, before, pregnancy, vaccinated
Federal

The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines builds on the Consortium's May 2020 pledge to work together to counter the COVID-19 global pandemic.

Last Updated: Jun. 30, 2021
Date Published: Jan. 21, 2021
Organization: Health Canada
Formats: HTML
Keywords:  coronavirus, COVID-19, vaccines, international, medications, drugs, biologics, Health Canada
Federal

The file comprises COVID-19 case counts, population, demographic and air pollution data by health region. The data were employed in a national ecological study of the association between air pollution and incidence of COVID-19. Data were obtained from the COVID-19 Canada Open Data portal, the Canadian Urban Environmental Health Research Consortium (CANUE), Statistics Canada and Google COVID-19 Community Mobility Reports. The study found that there was a positive association between COVID-19 incidence and long-term exposure to fine particulate matter (PM2.5).

Last Updated: Apr. 13, 2022
Date Published: Aug. 12, 2021
Organization: Health Canada
Formats: XLSX CSV
Keywords:  air pollution, fine particulate matter, PM2.5, COVID-19, health region
Federal

People infected with COVID-19 can shed the virus through their stool, even if they don't have any symptoms. Testing a community's sewage (wastewater) can tell us if COVID-19 is increasing or decreasing in that community. Our scientists have developed a pan-Canadian wastewater network to monitor the spread of COVID-19 in Canada. This is in collaboration with provincial, territorial and municipal governments and academia across Canada.

Last Updated: Aug. 3, 2022
Date Published: Apr. 29, 2022
Organization: Public Health Agency of Canada
Formats: CSV HTML
Keywords:  Wastewater samples, wastewater, COVID-19
Date modified: